Comparing Acupuncture With Medication to Reduce Anxiety and Depression in China (NCT07552246) | Clinical Trial Compass
Not Yet RecruitingPhase 4
Comparing Acupuncture With Medication to Reduce Anxiety and Depression in China
China120 participantsStarted 2026-04-01
Plain-language summary
The main objective of this study is to compare medication (usual care) with acupuncture (as a standalone comparator) to identify the most (cost)effective and environmentally sustainable intervention to reduce anxiety and mild to moderate depression in adults in China.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Chinese nationals 18 years old and above
✓. No mental health treatment in the past 6 months
✓. The patient diagnosis should meet one of the following ICD-10 diagnostic codes (or diagnosed as depressive state/anxiety state/anxious depression state):
✓. Depressive disorder (F30-F39)
✓. Fear anxiety disorder (F40)
✓. Other anxiety disorders (F41)
✓. Adjustment disorder (F43.2)
✓. Organic/secondary related disorders (F06)
Exclusion criteria
✕. Serious cardiovascular, cerebrovascular, liver, kidney and other serious life-threatening primary diseases
✕. Poorly controlled diabetes
✕. There is a risk of suicide
✕. Those with head trauma, loss of consciousness or severe mental disorders
✕. Drug, drug or alcohol abusers
✕. Received modified electrical convulsions (MECT/ECT), repetitive transcranial magnetic stimulation (r-TMS), vagus electrical stimulation (VNS), within half a year.
What they're measuring
1
Between-groups and within-subjects mean change in depression
Timeframe: Collected at baseline T0, after intervention T1 (after 3-4 weeks intervention), and at 3-month follow-up T2.
2
Between-groups and within-subjects mean change in anxiety
Timeframe: Collected at baseline T0, after intervention T1 (after 3-4 weeks intervention), and at 3-month follow-up T2.